15 Deoxy Δ12,14 PGJ2 Induces Procoagulant Activity in Cultured Human Endothelial Cells
暂无分享,去创建一个
M. Scully | V. Kakkar | D. O'regan | S. Xie | Shaoping Xie | David O’Regan | Vijay Kakkar | Michael Scully
[1] B. Rovin,et al. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma. , 2001, Biochemical and biophysical research communications.
[2] P. Libby,et al. PPARalpha activators inhibit tissue factor expression and activity in human monocytes. , 2001, Circulation.
[3] B. Binder,et al. Specificity, diversity, and convergence in VEGF and TNF‐α signaling events leading to tissue factor up regulation via EGR‐1 in endothelial cells , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] M. Lazar. Progress in cardiovascular biology: PPAR for the course , 2001, Nature Medicine.
[5] C. Glass,et al. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway , 2000 .
[6] D. Bishop-Bailey. Peroxisome proliferator‐activated receptors in the cardiovascular system , 2000, British journal of pharmacology.
[7] C. Esmon,et al. Metalloproteolytic Release of Endothelial Cell Protein C Receptor* , 2000, The Journal of Biological Chemistry.
[8] G. Natoli,et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase , 2000, Nature.
[9] J. Holder,et al. PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. , 2000, Trends in pharmacological sciences.
[10] V. Kakkar,et al. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[11] T. Hla,et al. Endothelial Cell Apoptosis Induced by the Peroxisome Proliferator-activated Receptor (PPAR) Ligand 15-Deoxy-Δ12,14-prostaglandin J2 * , 1999, The Journal of Biological Chemistry.
[12] D. Gilroy,et al. Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.
[13] B. Binder,et al. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. , 1999, Blood.
[14] C. Reutelingsperger,et al. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. , 1998, Cytometry.
[15] K. Colston,et al. Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells. , 1997, The Journal of endocrinology.
[16] A. Karsan,et al. Apoptotic vascular endothelial cells become procoagulant. , 1997, Blood.
[17] K. Nagata,et al. Anticoagulant effects of retinoic acids on leukemia cells. , 1996, Blood.
[18] A. Kolstø,et al. Cell biology of tissue factor, the principal initiator of blood coagulation. , 1996, Thrombosis research.
[19] J. Lehmann,et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.
[20] N. Mackman. Regulation of the tissue factor gene , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] F. Bach,et al. Regulation of the Tissue Factor Promoter in Endothelial Cells , 1995, The Journal of Biological Chemistry.
[22] B. Spiegelman,et al. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. , 1995, Cell.
[23] C. Esmon,et al. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. , 1994, The Journal of biological chemistry.
[24] M. Scully,et al. Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces. , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[25] N. Mackman,et al. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites , 1991, The Journal of experimental medicine.
[26] J. Sadler,et al. Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms. , 1991, Blood.
[27] J. Sadler,et al. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. , 1989, The Journal of biological chemistry.
[28] C. Esmon,et al. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. , 1989, Blood.
[29] W. Fiers,et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[30] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[31] F. Fitzpatrick,et al. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. , 1983, The Journal of biological chemistry.
[32] E. Jaffe,et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.